Dr. Rishal Rahman P: WARFARIN – Balancing Clot Prevention With Safe Monitoring
Dr. Rishal Rahman P, Clinical Pharmacist Intern at Aster MIMS Kottakkal, posted on LinkedIn:
”Day 14: WARFARIN – Balancing Clot Prevention with Safe Monitoring
Indications
Prevention and treatment of venous thromboembolism (VTE, DVT, PE)
Prevention of stroke/systemic embolism in atrial fibrillation
Prosthetic heart valve thromboprophylaxis
Secondary prevention after myocardial infarction
Mechanism of Action
Inhibits Vitamin K epoxide reductase complex (VKORC1) → prevents activation of clotting factors II, VII, IX, X and proteins C & S → ↓ coagulation.
Dosage
Initial: 2–5 mg/day orally
Maintenance: 2–10 mg/day (adjust per INR)
Target INR:
2.0–3.0 for most indications
2.5–3.5 for mechanical prosthetic valves
Clinical Pharmacist Tips
Monitor INR regularly (every 2–4 weeks once stable).
Maintain consistent dietary vitamin K intake (avoid sudden ↑/↓ in green leafy vegetables).
Strong drug–drug & food interactions → always check before prescribing.
Educate patients about bleeding signs (bruising, gum bleed, black stools).
Contraindications
Pregnancy (teratogenic)
Active bleeding, recent major surgery, hemorrhagic stroke
Severe uncontrolled hypertension
Poor compliance for monitoring
Drug Interactions
Increased effect (↑ bleeding risk): Antibiotics (e.g., metronidazole, TMP-SMX), amiodarone, antifungals, SSRIs
Decreased effect (↓ anticoagulation): Rifampin, carbamazepine, barbiturates, vitamin K-rich foods
NSAIDs, aspirin → ↑ bleeding risk (even without INR changes)
Adverse Drug Reactions (ADR)
Bleeding (most common, dose-dependent)
Skin necrosis (rare, usually within 3–10 days, esp. in protein C/S deficiency)
Purple toe syndrome
Teratogenicity (nasal hypoplasia, stippled epiphyses)”
Stay informed with Hemostasis Today.
-
Apr 14, 2026, 12:46Rosa Hart: Inside Pediatric Stroke Recovery with Dr. Catherine Schuster
-
Apr 14, 2026, 12:39Gonzalo Ladreda: Innovation in Stroke Care Is About Timing, Integration, and Real-World Usability
-
Apr 14, 2026, 12:30Roy P.C. Kessels: Stroke’s Cognitive Impact on Young Adults Is Significant and Often Overlooked
-
Apr 14, 2026, 12:22Mehari Gebreyohanns: New Insights on Wake-Up Strokes from Emergency Settings in Texas and Louisiana
-
Apr 14, 2026, 12:08Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026
-
Apr 14, 2026, 11:39Prachi Patel: How B Vitamins and Large-Scale Research Are Shaping Stroke Prevention
-
Apr 14, 2026, 11:28Jamie Brannigan: Help Shape the Future of Brain-Computer Interfaces in Stroke and Neurological Care
-
Apr 14, 2026, 11:18David Ferri: A Fontan Conduit Thrombosis Managed With an Innovative Catheter-Based Thrombectomy
-
Apr 14, 2026, 09:51Understanding Bleeding Disorder of Unknown Cause – EHC